These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11550057)

  • 41. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.
    Pietinalho A; Tukiainen P; Haahtela T; Persson T; Selroos O
    Chest; 1999 Aug; 116(2):424-31. PubMed ID: 10453872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis.
    Spiteri MA; Newman SP; Clarke SW; Poulter LW
    Eur Respir J; 1989 Mar; 2(3):218-24. PubMed ID: 2525101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of local and systemic budesonide on allergen-induced airway reactions in the pig.
    Fornhem C; Dahlbäck M; Kumlin M; Lundberg JM; Alving K
    Br J Pharmacol; 1996 Jun; 118(4):989-97. PubMed ID: 8799573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR; Koëter GH; van der Mark TW; Postma DS
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled budesonide inhibits OVA-induced airway narrowing, inflammation, and cys-LT synthesis in BN rats.
    Xu L; Olivenstein R; Martin JG; Powell WS
    J Appl Physiol (1985); 2000 Nov; 89(5):1852-8. PubMed ID: 11053336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The output of budesonide from nebulizers.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1998 Aug; 102(2):321-2. PubMed ID: 9723679
    [No Abstract]   [Full Text] [Related]  

  • 47. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD.
    Sun X; He Z; Zhang J; Deng J; Bai J; Li M; Zhong X
    Pulm Pharmacol Ther; 2015 Apr; 31():111-6. PubMed ID: 25281894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Chest; 1998 Oct; 114(4):1022-7. PubMed ID: 9792571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lavender essential oil inhalation suppresses allergic airway inflammation and mucous cell hyperplasia in a murine model of asthma.
    Ueno-Iio T; Shibakura M; Yokota K; Aoe M; Hyoda T; Shinohata R; Kanehiro A; Tanimoto M; Kataoka M
    Life Sci; 2014 Jul; 108(2):109-15. PubMed ID: 24909715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy.
    Perkins MW; Wong B; Rodriguez A; Devorak JL; Alves DA; Murphy G; Sciuto AM
    Chem Biol Interact; 2013 Dec; 206(3):452-61. PubMed ID: 23886498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
    Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
    J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphomatoid granulomatosis mimicking interstitial lung disease.
    Braham E; Ayadi-Kaddour A; Smati B; Ben Mrad S; Besbes M; El Mezni F
    Respirology; 2008 Nov; 13(7):1085-7. PubMed ID: 18699810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Budesonide/formoterol: in chronic obstructive pulmonary disease.
    Reynolds NA; Perry CM; Keating GM
    Drugs; 2004; 64(4):431-41; discussion 433-4. PubMed ID: 14969576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of sterically stabilized liposomes to treat asthma.
    Konduri KS; Nandedkar S; Rickaby DA; Düzgüneş N; Gangadharam PR
    Methods Enzymol; 2005; 391():413-27. PubMed ID: 15721394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease.
    Deng X; Zhang Z; Gu W; Li Y; Liu M
    Exp Lung Res; 2012 Aug; 38(6):295-301. PubMed ID: 22646473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pulmonary benign lymphocytic angiitis and granulomatosis--a benign lymphoproliferative condition].
    Marica C; Galbenu P; Galie N; Tănăsescu M
    Pneumologia; 2002; 51(4):302-5. PubMed ID: 12693170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment.
    Corteling R; Trifilieff A
    BMC Pharmacol; 2004 Apr; 4():4. PubMed ID: 15086961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen.
    Swystun VA; Bhagat R; Kalra S; Jennings B; Cockcroft DW
    J Allergy Clin Immunol; 1998 Sep; 102(3):363-7. PubMed ID: 9768574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.